-
The FDA has approved the first once-daily, quaternary ammonium, anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease.
-
As determined by process-of-care measurement, adverse event occurrence, and patient satisfaction, quality of care is compromised by infection control procedures.
-
For unvaccinated or high-risk vaccinated patients during the influenza season, empirical oseltamivir treatment is cost-effective. For other patients, rapid diagnostic testing followed by treatment with oseltamivir is cost-effective. Empirical amantadine treatment offers a low-cost alternative if patients cannot afford oseltamivir.
-
-
-
Olsen SJ, Chang HL, Vheung T, et al. Transmission of the severe acute respiratory syndrome (SARS) on aircraft. N Engl J Med 2003: 349:2,416-2,422.
-
Many questions continue to circle around the use of central venous catheter (CVC) devices. What are the demographics of their use and the practices of their insertion? How dangerous are they? What location in the hospital is CVC use most prevalent? What are ways to limit infection? Are there special considerations to treat infections, including bloodstream infections (BSI), resulting from the use of CVCs?
-
Crisis response mode and rapidly emerging infections are the new normal for a public health system that has to expect new threats as part of the daily job, warned Julie Gerberding, MD, MPH, director of the Centers for Disease Control and Prevention (CDC).
-
Though annual respirator fit-testing is being widely criticized, an infection control professional strongly recommends the practice after seeing a group of co-workers get infected with tuberculosis even though they were wearing N95 respirators.
-
In a formal letter to the Occupational Safety and Health Administration (OSHA) regarding its recently announced tuberculosis requirements, the Association for Professionals in Infection Control and Epidemiology (APIC) made the following key objections to the action.
